BIOVOX
BIOVOX redefines plastics for drug delivery devices and pharmaceutic packaging with medical-grade bioplastics. BIOVOX’s materials are free from critical substances, such as BPA, PFAS and phthalates and offer up to 85% lower carbon footprints.
BIOVOX redefines plastics for drug delivery devices and pharmaceutic packaging with medical-grade bioplastics. BIOVOX’s materials are free from critical substances, such as BPA, PFAS and phthalates and offer up to 85% lower carbon footprints while ensuring full regulatory compliance and patient safety. By using renewable feedstocks, adhering to ISO 13485-certified quality management and conducting rigorous biological safety testing, BIOVOX provides sustainable, high-performance alternatives for the pharma industry.
BIOVOX is privately owned and was founded in 2021.
